BIOMONITOR IIIm

With its breakthrough RhythmCheck algorithm, BIOMONITOR IIIm greatly reduces time-consuming ECG reviews of episodes falsely detected as atrial fibrillation.

• RhythmCheck eliminates 78% of false positive AF detections of patients with ectopic beats⁹
• 52% of false positive detections are due to ectopic beats⁷
• RhythmCheck recognizes every single ectopic beat and avoids them being misinterpreted as atrial fibrillation
• For maximum precision, the intelligent RhythmCheck algorithm dynamically adjusts to each patient’s unique rhythm

From injection to diagnosis, BIOMONITOR IIIm enhances workflow efficiency in every step  of delivering a timely and accurate diagnosis.

• One-Step Injection with a preloaded ICM makes it ideally suitable for in-office procedures
• During the One-Step Injection, the median time from incision to tool removal was 39 seconds²
• Fully automated, zero set-up Home Monitoring provides an industry-leading transmission compliance rate of 98%³
• Also industry leading is 5.5 years longevity, particularly valuable for patient groups that benefit from extended monitoring
• A unique Ectopy Counter provides count and trend data for the last 240 days — a potential marker for HF, AF, and stroke risk
• An optional Patient App with a Home Monitoring synchronized symptom diary facilitates fast evaluation of rhythm-symptom correlations
• MRI scanning can be perfomed without any waiting period after injection, as the device is 1,5T and 3,0T full-body MR conditional